Verdict at a Glance Both Dihexa and PE-22-28 are preclinical nootropic peptides with no human data, making any clinical recommendation premature
drugs under pre-clinical or clinical development or discontinued, designer drugs, substances approved only for veterinary use) is prohibited at all times. So, to summarize: BPC-157 may be beneficial in healing orthopedic injuries, but it is not approved for FDA usage and therefore banned under the WADA Code
At Better You Rx, you can join the waitlist for Retatrutide and fill up the consultation form
Find out if there is evidence for this, if this increases lifespan or longevity, plus safety, side effects and cost
Biomarker studies: establishing senescent cell burden diagnostic (e.g., imaging, blood markers) to monitor effect and guide dosing